Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
CareDx has acquired Naveris, a diagnostics imaging business in New York, for $260 million. Naveris provides diagnostic imaging capabilities used in clinical workflows, supporting oncology-focused testing and patient management. CareDx acquisitions aim to expand healthcare diagnostics offerings and strengthen its presence in NY acquisitions for advanced laboratory and imaging-related services. The CareDx acquisition is a strategic acquisition under healthcare M&A, valued at up to $260 million and announced as an acquisition acquisition.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026